Claro Advisors’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$721K Sell
8,462
-1,454
-15% -$130K 0.09% 183
2025
Q4
$784K Buy
9,916
+259
+3% +$20.3K 0.11% 169
2025
Q3
$772K Sell
9,657
-415
-4% -$35.4K 0.11% 160
2025
Q2
$916K Sell
10,072
-7,578
-43% -$692K 0.15% 129
2025
Q1
$1.65M Sell
17,650
-604
-3% -$54.1K 0.22% 83
2024
Q4
$1.66M Sell
18,254
-3,926
-18% -$375K 0.22% 85
2024
Q3
$2.3M Buy
22,180
+1,364
+7% +$139K 0.3% 63
2024
Q2
$2.02M Buy
20,816
+482
+2% +$44.5K 0.32% 58
2024
Q1
$1.83M Buy
20,334
+697
+4% +$59.1K 0.32% 57
2023
Q4
$1.57M Sell
19,637
-473
-2% -$35.6K 0.34% 61
2023
Q3
$1.43M Buy
20,110
+2,672
+15% +$200K 0.36% 61
2023
Q2
$1.34M Buy
17,438
+683
+4% +$52.9K 0.33% 65
2023
Q1
$1.26M Buy
16,755
+515
+3% +$38.3K 0.37% 63
2022
Q4
$1.28M Sell
16,240
-245
-1% -$18.4K 0.42% 57
2022
Q3
$1.32M Hold
16,485
0.53% 42
2022
Q2
$1.32M Buy
16,485
+3,556
+28% +$278K 0.53% 42
2022
Q1
$1.1M Hold
12,929
0.4% 61
2021
Q4
$1.1M Buy
12,929
+164
+1% +$12.8K 0.4% 61
2021
Q3
$965K Buy
12,765
+1,908
+18% +$152K 0.41% 61
2021
Q2
$883K Buy
10,857
+173
+2% +$14.1K 0.4% 58
2021
Q1
$842K Buy
10,684
+257
+2% +$20.1K 0.43% 61
2020
Q4
$892K Sell
10,427
-325
-3% -$26.9K 0.47% 57
2020
Q3
$830K Sell
10,752
-63
-0.6% -$4.8K 0.53% 46
2020
Q2
$792K Sell
10,815
-84
-0.8% -$5.97K 0.55% 48
2020
Q1
$723K Buy
10,899
+142
+1% +$10K 0.67% 36
2019
Q4
$741K Buy
10,757
+94
+0.9% +$6.41K 0.57% 47
2019
Q3
$784K Buy
10,663
+230
+2% +$16.7K 0.7% 40
2019
Q2
$748K Buy
10,433
+1,324
+15% +$94K 0.69% 41
2019
Q1
$624K Sell
9,109
-27
-0.3% -$1.74K 0.62% 48
2018
Q4
$612K Buy
+9,136
New +$572K 0.49% 43

Other funds holding CL

Claro Advisors's CL Position: Q1 2026 in Review

Claro Advisors reduced its Colgate-Palmolive (CL) stake by 15% in Q1 2026, selling an estimated $130K and leaving 8,462 shares worth $721K. The position accounts for 0.09% of the portfolio, ranked #183.

Claro Advisors first reported a position in CL in Q4 2018 and has held it in 30 quarters since. The position peaked at $2.3M in Q3 2024. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Claro Advisors held 8,462 shares of Colgate-Palmolive worth $721K as of Q1 2026.
  • Claro Advisors sold 1,454 Colgate-Palmolive shares in Q1 2026, an estimated $130K.
  • Colgate-Palmolive made up 0.09% of Claro Advisors's portfolio in Q1 2026, its #183 holding.
  • Claro Advisors first reported a position in Colgate-Palmolive in Q4 2018 and has held it in 30 quarters since.
  • Claro Advisors's Colgate-Palmolive position peaked at $2.3M in Q3 2024.
  • 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Claro Advisors's 13F filing for Q1 2026, filed 21 Apr 2026.